21st April 2021
Germany-based start-up, Clinomic, has announced successfully closing their latest funding round with a total of seven million euros.
Clinomic, which has been supported by various EIT Health activities, is developing a new solution to revolutionise patient care within intensive care units. As part of the solution, data from diagnostic devices are aggregated onto a single screen, while artificial intelligence is used to analyse the data and present healthcare professionals with support in decision making and efficient use of time and resources.
“The way intensive care is practised today can no longer continue. The burden on medical and nursing staff is high and the complexity continues to increase. Artificial intelligence algorithms can help us to rectify this situation. After all, doctors should have more time for their patients rather than having to spend it in front of screens,” said Arne Peine and Lukas Martin, Co-Founders of Clinomic, in a joint statement.
The team has been supported by EIT Health throughout their journey – gaining support on developing their business via the accelerator, and in developing the product itself as part of an EIT Health project which ran in 2019 and 2020.
Their latest funds will be utilised to further develop their solution to bring Clinomic closer to a reality of optimising the management of patients within intensive care.
EIT Health Bootcamp selects 11 female-led start-ups
Connecting women-led teams to mentors and investors
EIT Health selecting three Supervisory Board members
Independent members sought; apply by 23 May
Bridgehead announces first start-ups for 2021
Helping SMEs expand in Europe and beyond